2019 Update on Genetic Testing for Hereditary Breast and Ovarian Cancer

The field of cancer genetics has changed significantly over the past five years. Recommendations for BRCA-related cancers, genetic counseling, and genetic testing should consider individuals affected with breast, ovarian, and prostate cancer.

2016 Update on USPSTF Breast Cancer Screening Recommendations

The U.S. Preventive Services Task Force released a final recommendation statement on breast cancer screening, reiterating the same guidance it offered in its last recommendation statement 7 years ago. Comments from Dr. Susan Boolbol on January 11, 2016

Comments on USPSTF Review of Medications to Reduce the Risk for Primary Breast Cancer

The USPSTF recently undertook a review of the topic of chemoprevention of primary breast cancer; that is, the use of pharmaceutical agents (i.e., selective estrogen receptor modulators, SERMs) to lower a high risk woman’s chances for developing the disease.

Our Launch and First Press Release in 2012!

"ISC-RAM is the first society focused on advancing the knowledge of cancer risk assessment and education globally, which currently does not exist," said Banu Arun, M.D., Director of Clinical Cancer Genetics and Clinical Cancer Prevention Program at the MD Anderson Cancer Center. "By focusing on cancer risk assessment and management, this multidisciplinary group will facilitate efforts to reduce the burden of cancer in our society," said Freya Schnabel, M.D., Director of Breast Surgery at NYU Langone Medical Center.